{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:34:27Z","timestamp":1771101267643,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013129","name":"Korea Ministry of SMEs and Startups","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.transproceed.2023.12.018","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T10:54:32Z","timestamp":1708080872000},"page":"440-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Effects of Busulfan on Xenogeneic Transplantation of Human Peripheral Blood Mononuclear Cells in Recipient Mice"],"prefix":"10.1016","volume":"56","author":[{"given":"Inseon","family":"Bak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeongjin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhye","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong-Won","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo Yule","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minseong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Sik","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Yeul","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.12.018_bib0001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2011.06318.x","article-title":"Humanized mice for the study of type 1 and type diabetes","volume":"1245","author":"Greiner","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06310.x","article-title":"Humanized mice as a preclinical tool for infectious disease and biomedical research","volume":"1245","author":"Shultz","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/335256a0","article-title":"Transfer of a functional human immune system to mice with severe combined immunodeficiency","volume":"335","author":"Mosier","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0004","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hematopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nature Rev Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0006","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor {gamma} chain(null) mice","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0007","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0008","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.176.4.2053","article-title":"Experimental models to study development and function of the human immune system in vivo","volume":"176","author":"Legrand","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2007.11.001","article-title":"A new Hu-PBL model for the study of human islet alloreactivity based on NOD-SCID mice bearing a targeted mutation in the IL-2 receptor gamma chain gene","volume":"126","author":"King","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4161\/mabs.29111","article-title":"Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies","volume":"6","author":"Wege","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0011","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00262-008-0632-0","article-title":"Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD\/Shi-scid, IL2Rgamma(null) mouse model","volume":"58","author":"Ito","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0012","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-3510","article-title":"Nivolumab and urelumab enhance the antitumor activity of human T lymphocytes engrafted in Rag2-\/-IL2Rgnull immunodeficient mice","volume":"75","author":"Sanmamed","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0013","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nature Rev Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001513","article-title":"Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model","volume":"8","author":"Park","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0015","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.bbmt.2019.08.012","article-title":"Comparison of high doses of total body irradiation in myeloablative conditioning before hematopoietic cell transplantation","volume":"25","author":"Sabloff","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","article-title":"Busulfan produces efficient human cell engraftment in NOD\/LtSz-Scid IL2Rgamma(null) mice","volume":"27","author":"Hayakawa","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0017","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007890-198808000-00004","article-title":"Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan","volume":"46","author":"Mauch","year":"1988","journal-title":"Transplant"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0018","first-page":"913","article-title":"Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs","volume":"21","author":"Down","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0019","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.exphem.2007.05.009","article-title":"Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts","volume":"35","author":"Hsieh","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1995.tb31039.x","article-title":"Preparative regimens: chemotherapy versus chemoradiotherapy. A historical perspective","volume":"770","author":"Santos","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0021","first-page":"1384","article-title":"Human cell engraftment after busulfan or irradiation conditioning of NOD\/SCID mice","volume":"91","author":"Robert-Richard","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10875-010-9478-2","article-title":"Human B cell development and antibody production in humanized NOD\/SCID\/IL-2R\u03b3(null) (NSG) mice conditioned by busulfan","volume":"31","author":"Choi","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0023","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10875-011-9538-2","article-title":"Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD\/SCID\/IL-2R\u03b3null (NSG) mice","volume":"31","author":"Kim","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0024","doi-asserted-by":"crossref","first-page":"e74361","DOI":"10.1371\/journal.pone.0074361","article-title":"Busulfan administration flexibility increases the applicability of scid repopulating cell assay in NSG mouse model","volume":"8","author":"Chevaleyre","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0025","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.bbmt.2016.04.013","article-title":"Intravenous busulfan-based myeloablative conditioning regimens prior to hematopoietic cell transplantation for hematologic malignancies","volume":"22","author":"Pasquini","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0026","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.omtm.2019.10.017","article-title":"Low-dose busulfan reduces human CD34+ cell doses required for engraftment in c-kit mutant immunodeficient mice","volume":"15","author":"Leonard","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5045\/br.2016.51.1.31","article-title":"Humanizing NOD\/SCID\/IL-2R\u03b3null (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34(+) cells","volume":"51","author":"Kang","year":"2016","journal-title":"Blood Res"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0028","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/0963689719842162","article-title":"The preconditioning of busulfan promotes efficiency of human CD133+ cells engraftment in NOD Shi-SCID IL2R\u03b3cnull (NOG) mice via intra-bone marrow injection","volume":"28","author":"Guo","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0029","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","article-title":"Humanized mice for the study of immuno-oncology","volume":"39","author":"De La Rochere","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42826-020-00048-y","article-title":"Two base pair deletion in IL2 receptor \u03b3 gene in NOD\/SCID mice induces a highly severe immunodeficiency","volume":"36","author":"Bak","year":"2020","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0031","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0032","doi-asserted-by":"crossref","first-page":"12963","DOI":"10.1096\/fj.202001203R","article-title":"A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome","volume":"34","author":"Ye","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149093","article-title":"TGN1412 Induces lymphopenia and human cytokine release in a humanized mouse model","volume":"11","author":"Wei\u00dfm\u00fcller","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fonc.2020.00549","article-title":"The use of a humanized NSG-\u03b22m -\/- model for investigation of immune and anti-tumor effects mediated by the bifunctional immunotherapeutic Bintrafusp Alfa","volume":"10","author":"Morillon","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0035","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.4049\/jimmunol.164.5.2496","article-title":"NOD\/LtSz-Rag1nullMice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid ells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells","volume":"164","author":"Shultz","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0036","doi-asserted-by":"crossref","first-page":"25751","DOI":"10.18632\/oncotarget.25399","article-title":"Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine","volume":"9","author":"Sasaki","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0037","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41409-021-01363-1","article-title":"Itacitinib prevents xenogeneic GVHD in humanized mice","volume":"56","author":"Courtois","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00005-018-0506-x","article-title":"Humanized mice as unique tools for human-specific studies","volume":"66","author":"Yong","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0039","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20071641","article-title":"Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates","volume":"205","author":"Sarkar","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.transproceed.2023.12.018_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/eji.201847517","article-title":"Plasma cells: The programming of an antibody-secreting machine","volume":"49","author":"Tellier","year":"2019","journal-title":"Eur J Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:47:04Z","timestamp":1758577624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0041134524000666"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.018","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Busulfan on Xenogeneic Transplantation of Human Peripheral Blood Mononuclear Cells in Recipient Mice","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}